Daniel Hume
Direktor/Vorstandsmitglied bei TG THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Daniel Hume
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TG THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2015 | - |
Independent Dir/Board Member | 01.04.2015 | - | |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - | - |
Kirby Mcinerney LLP
Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Corporate Officer/Principal | 01.01.1995 | - |
Supreme Court of the United States | Corporate Officer/Principal | - | - |
United States District Court for the Southern District of NY | Corporate Officer/Principal | - | - |
United States District Court for the Eastern District of NY | Corporate Officer/Principal | - | - |
United States Court of Appeals for the Second Circuit | Corporate Officer/Principal | - | - |
United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | - | - |
Daniel M. Hume, M.D. PA | Präsident | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Karriereverlauf von Daniel Hume
Ehemalige bekannte Positionen von Daniel Hume
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Daniel Hume
State University of New York at Albany | Undergraduate Degree |
Columbia Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Operativ
Corporate Officer/Principal | 7 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 4 |
Government | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TG THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
Kirby Mcinerney LLP
Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Commercial Services |
National Holdings Corp.
National Holdings Corp. Investment Banks/BrokersFinance National Holdings Corp. engages in the provision of investment banking and asset management services. It operates through the following segments: Brokerage and Advisory Services and Tax and Accounting Services. The Brokerage and Advisory Services segment includes broker-dealer and investment advisory services, sale of insurance products and licensed mortgage brokerage services. The Tax and Accounting Services segment involves tax preparation and accounting services provided by National Tax. The company was founded in 1947 and is headquartered in New York, NY. | Finance |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Supreme Court of the United States | Government |
United States District Court for the Southern District of NY | Government |
United States District Court for the Eastern District of NY | Government |
United States Court of Appeals for the Second Circuit | |
United States Court of Appeals For The Fourth Circuit | |
Daniel M. Hume, M.D. PA | |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Daniel Hume
- Erfahrung